Published in Anal Biochem on January 21, 2017
Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A (1990) 17.55
Improved method for accurate and efficient quantification of MRS data with use of prior knowledge J Magn Reson (1997) 6.84
Determination of intracellular pH by 31P magnetic resonance. J Biol Chem (1973) 6.71
NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A (1982) 4.95
Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest (1974) 4.79
Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature (1980) 3.86
Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med (2001) 3.32
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation (1992) 3.27
Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N Engl J Med (1981) 3.00
Standard magnetic resonance-based measurements of the Pi→ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles. Am J Physiol Cell Physiol (2011) 2.53
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 2.52
A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol (1988) 2.49
Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol (1990) 2.45
Studies of human tumors by MRS: a review. NMR Biomed (1993) 2.44
Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J (2005) 2.34
Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab (2006) 2.31
Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann N Y Acad Sci (1977) 2.26
Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. Am J Physiol (1985) 2.21
Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed (2007) 2.21
Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol (1993) 2.13
Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA (1999) 2.12
In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: an initial experience. Magn Reson Med (2003) 2.09
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation (2003) 2.01
NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97
Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia (2006) 1.97
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A (1985) 1.86
Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study. Proc Natl Acad Sci U S A (1981) 1.85
Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review. Magn Reson Q (1994) 1.84
Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. Proc Natl Acad Sci U S A (1992) 1.83
Quantitative cardiac 31P spectroscopy at 3 Tesla using adiabatic pulses. Magn Reson Med (2009) 1.83
Interpretation of ³¹P NMR saturation transfer experiments: what you can't see might confuse you. Focus on "Standard magnetic resonance-based measurements of the Pi→ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles". Am J Physiol Cell Physiol (2011) 1.77
Skeletal muscle enzymes and fiber composition in male and female track athletes. J Appl Physiol (1976) 1.66
Selective excitation in Fourier transform nuclear magnetic resonance. 1978. J Magn Reson (2011) 1.62
Four-angle saturation transfer (FAST) method for measuring creatine kinase reaction rates in vivo. Magn Reson Med (2002) 1.58
Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first-pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2007) 1.54
31P-MRS of quadriceps reveals quantitative differences between sprinters and long-distance runners. Med Sci Sports Exerc (1993) 1.51
Design and testing of an MRI-compatible cycle ergometer for non-invasive cardiac assessments during exercise. Biomed Eng Online (2012) 1.49
Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology (2009) 1.49
Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2003) 1.47
The signal transduction function for oxidative phosphorylation is at least second order in ADP. J Biol Chem (1996) 1.43
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis (2007) 1.42
Noninvasive metabolic assessment of human donor livers: prognostic value of 31P-magnetic resonance spectroscopy for early graft function. Transplantation (1997) 1.40
Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med (2009) 1.40
Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care (2011) 1.36
Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol (2006) 1.35
NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer. Q Rev Biophys (1984) 1.34
The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology (2003) 1.34
BISTRO: an outer-volume suppression method that tolerates RF field inhomogeneity. Magn Reson Med (2001) 1.33
31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo. Biochemistry (1989) 1.32
Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy. J Physiol (2001) 1.29
Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed (2006) 1.27
Noninvasive measurement of phosphocreatine recovery kinetics in single human muscles. Am J Physiol (1997) 1.26
Energy-rich phosphates in slow and fast human skeletal muscle. Am J Physiol (1995) 1.26
ATP production rate via creatine kinase or ATP synthase in vivo: a novel superfast magnetization saturation transfer method. Circ Res (2011) 1.23
Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol (2001) 1.23
Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Br Med J (Clin Res Ed) (1982) 1.21
Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med (1994) 1.21
Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol (2003) 1.20
Spatial localization in nuclear magnetic resonance spectroscopy. Phys Med Biol (2006) 1.20
Genetic determinism of fiber type proportion in human skeletal muscle. FASEB J (1995) 1.19
Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes (1999) 1.16
Neuromuscular adaptations during concurrent strength and endurance training versus strength training. Eur J Appl Physiol (2002) 1.16
Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy. Science (1985) 1.14
Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med (2001) 1.14
Comparison of MRI with EMG to study muscle activity associated with dynamic plantar flexion. Magn Reson Imaging (2003) 1.14
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Transceiver-Phased Arrays for Human Brain Studies at 7 T. Appl Magn Reson (2011) 1.12
Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy. Lancet (1987) 1.12
Corrections for off-resonance effects and incomplete saturation in conventional (two-site) saturation-transfer kinetic measurements. Magn Reson Med (2000) 1.12
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology (1995) 1.11
Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Cancer Res (1989) 1.11
An MR-compatible bicycle ergometer for in-magnet whole-body human exercise testing. Magn Reson Med (2010) 1.10
Ageing, muscle properties and maximal O(2) uptake rate in humans. J Physiol (2000) 1.10
In vivo 31P MRS of human brain at high/ultrahigh fields: a quantitative comparison of NMR detection sensitivity and spectral resolution between 4 T and 7 T. Magn Reson Imaging (2006) 1.09
Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review. Acta Physiol (Oxf) (2014) 1.09
Triple repetition time saturation transfer (TRiST) 31P spectroscopy for measuring human creatine kinase reaction kinetics. Magn Reson Med (2010) 1.09
Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol (1996) 1.08
Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed (1989) 1.08
Quantification of the 31P metabolite concentration in human skeletal muscle from RARE image intensity. Magn Reson Med (2004) 1.08
³¹P-magnetization transfer magnetic resonance spectroscopy measurements of in vivo metabolism. Diabetes (2012) 1.08
Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment. NMR Biomed (2008) 1.07
31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology (1987) 1.07
Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed (1994) 1.06
Comparison of oxidative capacity among leg muscles in humans using gated 31P 2-D chemical shift imaging. NMR Biomed (2009) 1.06
Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol (1986) 1.05
Muscle metabolism during exercise in young and older untrained and endurance-trained men. J Appl Physiol (1985) (1993) 1.05
Intersubject differences in the effect of acidosis on phosphocreatine recovery kinetics in muscle after exercise are due to differences in proton efflux rates. Am J Physiol Cell Physiol (2007) 1.04
High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. J Vasc Surg (2006) 1.04
Dynamic interleaved 1H/31P STEAM MRS at 3 Tesla using a pneumatic force-controlled plantar flexion exercise rig. MAGMA (2005) 1.03
Comparison of in vivo postexercise phosphocreatine recovery and resting ATP synthesis flux for the assessment of skeletal muscle mitochondrial function. Am J Physiol Cell Physiol (2010) 1.03
Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla. Magn Reson Med (2013) 1.02
What do magnetic resonance-based measurements of Pi→ATP flux tell us about skeletal muscle metabolism? Diabetes (2012) 1.02
Imaging of human brain creatine kinase activity in vivo. FASEB J (1989) 1.01
Creatine phosphate in fiber types of skeletal muscle before and after exhaustive exercise. J Appl Physiol (1985) (1989) 1.01
Linear relation between rate and thermodynamic force in enzyme-catalyzed reactions. Biochim Biophys Acta (1980) 1.01
A gated 31P NMR method for the estimation of phosphocreatine recovery time and contractile ATP cost in human muscle. NMR Biomed (2006) 0.99
Comparing localized and nonlocalized dynamic 31P magnetic resonance spectroscopy in exercising muscle at 7 T. Magn Reson Med (2012) 0.99
Skeletal muscle metabolism in individuals with spinal cord injury. J Appl Physiol (1985) (2011) 0.99
In vivo evidence of an age-related increase in ATP cost of contraction in the plantar flexor muscles. Clin Sci (Lond) (2014) 0.99